nalidixic acid has been researched along with amsacrine in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (30.77) | 18.7374 |
1990's | 7 (53.85) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Sumner, AT | 1 |
DeMarini, DM; Lawrence, BK | 2 |
Kort, L; Rowley, R | 1 |
Chen, GL; Hsiang, YH; Liu, LF; Rowe, TC | 1 |
Doida, Y; Fero, ML; Guo, XC; Morgan, WF; Shadley, JD | 1 |
Sitailo, LA; Zagariya, AM | 1 |
Creus, A; Marcos, R; Ribas, G; Xamena, N | 1 |
Jo, K; Topal, MD | 1 |
Rosen, JE; Schluter, G; Williams, GM | 1 |
Creus, A; Marcos, R; Torres, C | 1 |
13 other study(ies) available for nalidixic acid and amsacrine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis.
Topics: Amsacrine; Camptothecin; Chromosome Aberrations; Chromosomes, Human; Daunorubicin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Ellipticines; Ethidium; Etoposide; Humans; In Vitro Techniques; Lymphocytes; Mitosis; Mitoxantrone; Nalidixic Acid; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1992 |
Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species: role of DNA breaks.
Topics: Amsacrine; Azides; Bacteriophage lambda; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Ellipticines; Escherichia coli; Free Radicals; Hydrogen Peroxide; Lysogeny; Nalidixic Acid; Novobiocin; Oxolinic Acid; Oxygen; Paraquat; Sodium Azide; SOS Response, Genetics; Teniposide; Topoisomerase II Inhibitors; Virus Replication | 1992 |
Novobiocin, nalidixic acid, etoposide, and 4'-(9-acridinylamino)methanesulfon-m-anisidide effects on G2 and mitotic Chinese hamster ovary cell progression.
Topics: Amsacrine; Animals; Cell Line; Cell Survival; DNA Damage; Etoposide; Interphase; Metaphase; Mitosis; Nalidixic Acid; Novobiocin; RNA; Topoisomerase II Inhibitors | 1989 |
Mutagenicity of topoisomerase-active agents in bacteriophage T4.
Topics: Amsacrine; Dactinomycin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Ellipticines; Mutation; Nalidixic Acid; Novobiocin; Oxolinic Acid; T-Phages | 1988 |
DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.
Topics: Acridines; Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cattle; DNA; DNA Repair; DNA Topoisomerases, Type II; Mice; Nalidixic Acid; Phosphorus Radioisotopes; Tyrosine | 1986 |
Potentiation of sister chromatid exchange by 3-aminobenzamide is not modulated by topoisomerases or proteases.
Topics: Aminoacridines; Amsacrine; Animals; Antipain; Benzamides; Cricetinae; Cricetulus; DNA Topoisomerases, Type I; Female; Methyl Methanesulfonate; Nalidixic Acid; Novobiocin; Peptide Hydrolases; Poly(ADP-ribose) Polymerases; Sister Chromatid Exchange | 1986 |
The influence of antibiotics and antitumor agents on the relaxation activity of Pisum sativum leaf chloroplast topoisomerase I.
Topics: Amiloride; Amsacrine; Anti-Bacterial Agents; Antineoplastic Agents; Camptothecin; Chloroplasts; DNA Topoisomerases, Type I; DNA, Plant; Ethidium; Heparin; Indoles; Magnesium; Nalidixic Acid; Novobiocin; Pisum sativum; Polyamines; Topoisomerase I Inhibitors | 1995 |
Sister-chromatid exchanges (SCE) induction by inhibitors of DNA topoisomerases in cultured human lymphocytes.
Topics: Amsacrine; Camptothecin; Cells, Cultured; Enzyme Inhibitors; Etoposide; Humans; Lymphocytes; Mitomycin; Nalidixic Acid; Sister Chromatid Exchange; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1996 |
Changing a leucine to a lysine residue makes NaeI endonuclease hypersensitive to DNA intercalative drugs.
Topics: Amsacrine; Antineoplastic Agents; Binding Sites; Daunorubicin; Deoxyribonuclease EcoRI; Deoxyribonucleases, Type II Site-Specific; DNA Nucleotidyltransferases; DNA Topoisomerases, Type I; Ellipticines; Enzyme Inhibitors; Integrases; Intercalating Agents; Kinetics; Lysine; Nalidixic Acid; Novobiocin; Oxolinic Acid; Point Mutation; Recombinant Proteins; Recombinases; Topoisomerase I Inhibitors | 1996 |
Lack of effects of ciprofloxacin and the topoisomerase II inhibitors, m-AMSA and nalidixic acid, on DNA repair in cultured rat liver cells.
Topics: Amsacrine; Animals; Autoradiography; Cells, Cultured; Ciprofloxacin; DNA Repair; DNA Topoisomerases, Type II; Liver; Male; Mutagenicity Tests; Nalidixic Acid; Rats; Rats, Inbred F344; Topoisomerase II Inhibitors | 1996 |
Genotoxic activity of four inhibitors of DNA topoisomerases in larval cells of Drosophila melanogaster as measured in the wing spot assay.
Topics: Amsacrine; Animals; Camptothecin; Drosophila melanogaster; Etoposide; Larva; Mutagens; Nalidixic Acid; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1998 |